Tuesday, September 20, 2011 10:20:48 AM
2011
MADISON HEIGHTS, Mich., Sep 20, 2011 (GlobeNewswire via COMTEX) -- InfuSystem
Holdings, Inc. (INFU) today announced it will release results for the third
quarter 2011 on Thursday, November 10, 2011. The Company will host a live
conference call and webcast at 10:00am Eastern time.
To participate in the call, you may dial toll-free (800)-447-0521. Please use
passcode 30770688. Alternatively, to hear the webcast in listen-only mode, or to
view the financial results, please visit the Investors section of the Company's
website at http://www.infusystem.com/investors. A replay of the webcast will be
available via the website for 30 days following the call.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is the leading provider of infusion pumps and related
services to hospitals, oncology practices and other alternate site healthcare
providers. Headquartered in Madison Heights, Michigan, the company delivers
local, field-based customer support, and also operates Centers of Excellence in
Michigan, Kansas, California, and Ontario, Canada. The company's stock is traded
on the NYSE Amex under the symbol INFU.
This news release was distributed by GlobeNewswire, http://www.globenewswire.com
SOURCE: InfuSystem, Inc.
CONTACT: INVESTOR CONTACT:
Pat LaVecchia
Vice Chairman
Info@InfuSystem.com
Tel: (800) 962-9656
MEDIA CONTACT:
David Haar
Info@InfuSystem.com
Tel: (800) 962-9656
(C) Copyright 2010 GlobeNewswire, Inc
Recent INFU News
- InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024 • Business Wire • 05/02/2024 08:30:00 PM
- InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K • Business Wire • 04/03/2024 10:30:00 AM
- InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023 • Business Wire • 03/14/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 11:31:20 AM
- InfuSystem to Report Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 • Business Wire • 03/08/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:00:52 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:29:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:51:18 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/29/2023 10:08:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:30:42 PM
- InfuSystem to Present at Sidoti Small-Cap Virtual Conference on December 6, 2023 • Business Wire • 11/28/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:01:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:39:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:16:50 PM
- InfuSystem to Participate at 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023 • Business Wire • 11/09/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 11:31:00 AM
- InfuSystem Reports Third Quarter 2023 Financial Results • Business Wire • 11/07/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 10:41:12 AM
- InfuSystem to Report Third Quarter 2023 Financial Results on November 7, 2023 • Business Wire • 10/31/2023 10:30:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 09:51:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 09:17:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 10:38:58 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM